Somatropin prescribing across the NHS.
Somatropin has the narrowest prescriber base on this site: 37,000 items a year at £558 an item, written by fewer than 1,700 practices, nearly all of it paediatric endocrinology delivered through shared care. Tiny volume, £21m at list price, and a market that moves on specialist decisions, not primary-care ones.
The NHS in England dispensed 36,719 prescription items of Somatropin in the 12 months to July 2026, across primary care and hospitals.
Spending on Somatropin over those 12 months was £20.4m at net ingredient cost, the list price of what was dispensed before any discounts.
Items were down 3.1% on the previous 12 months.
36% of Somatropin volume moved through primary care and 64% through hospital pharmacies.
Somatropin is the largest of 9 chemical substances in Hypothalamic & anterior pituitary hormone & antioestrogens (BNF 6.5.1), by items dispensed.
Among Integrated Care Boards, NHS Greater Manchester ICB dispensed the highest volume of Somatropin.
Source: NHS Business Services Authority open data (English Prescribing Data and SCMD), OGL v3.0. Items count prescriptions dispensed, not patients treated.
Diamond markers show events around this period: NICE decisions, safety alerts, supply notices, Drug Tariff moves and price concessions, new suppliers in dm+d and framework awards. Hover a marker for the date and type. The evidence behind each one, with the source quote and link, sits behind Apply.
| Month | Items | Spend (NIC) |
|---|---|---|
| July 2026 | 3,319 | £1.9m |
| June 2026 | 3,072 | £1.7m |
| May 2026 | 2,907 | £1.6m |
| April 2026 | 3,048 | £1.7m |
| March 2026 | 3,150 | £1.8m |
| February 2026 | 2,774 | £1.6m |
| January 2026 | 3,108 | £1.7m |
| December 2025 | 3,179 | £1.8m |
| November 2025 | 2,937 | £1.6m |
| October 2025 | 3,187 | £1.8m |
| September 2025 | 3,172 | £1.8m |
| August 2025 | 2,866 | £1.6m |
The same series as the chart, most recent month first. The full monthly history, as CSV, sits behind Apply.
95.8% of its class.
Somatropin is the largest of 9 chemical substances in Hypothalamic & anterior pituitary hormone & antioestrogens (BNF 6.5.1), by items dispensed in July 2026. The full class league, who's gaining, and the month-by-month share movement sit behind Apply.
Average items by calendar month across the full history, indexed to the annual mean.
5 suppliers hold a live somatropin listing, across 24 packs.
Ferring Pharmaceuticals Ltd, Merck Serono Ltd, Novo Nordisk Ltd, Pfizer Ltd, Sandoz Ltd. Every pack, its GTIN and published list price, and each week's changes are in the full report.
A listing in the NHS Dictionary of Medicines and Devices means a product may be supplied. It says nothing about sales or market share, and the list price is the reimbursement price, not what any buyer pays. Contains information from dm+d 10.1.0, published by the NHS Business Services Authority under the Open Government Licence v3.0.
Somatropin across all 33 ICBs.
Every Integrated Care Board in England, shaded by how much somatropin its GPs dispense per head of population. Hover an ICB to name it. The ranked figures for all 33 ICBs, and the drill-down to practice level, are in the full report.
Darker shading marks where Somatropin is dispensed most per head of population. Exact figures for every ICB, and the drill-down to practice level, are in the full report.
Zoomed out to the 7 NHS regions.
The same 12 months rolled up to NHS England's seven regions, ranked by intensity.
The teaser view.
Three rows each. The full 33-ICB view, every prescribing organisation, every strength and the hospital picture sit below the fold, behind Apply.
- 1 NHS Greater Manchester ICB 5k
- 2 NHS West Yorkshire ICB 4k
- 3 NHS Central East ICB 3k
- – + 30 more. See the full 33-ICB table. See all →
- 1 NHS Cornwall and the Isles of Scilly ICB +14.8%
- 2 NHS Norfolk and Suffolk ICB +5.9%
- 3 NHS South Yorkshire ICB +5.2%
- – + 30 more. See every ICB, ranked. See all →
- 1 Omnitrope SurePal 10 10mg/1.5ml inj cartridges 12%
- 2 Omnitrope SurePal 15 15mg/1.5ml inj cartridges 11%
- 3 Omnitrope SurePal 5 5mg/1.5ml inj cartridges 10%
- – + 3 more. See every strength and pack. See all →
Split of items across NHSBSA primary care and SCMD hospital dispensing.
Prescribing by deprivation.
Items per 1,000 registered patients by deprivation decile (1 = most deprived), practice deprivation weighted by where each practice's patients live. Read the shape rather than the absolute level: the most and least deprived deciles cover far fewer practices, and age structure drives much of the gradient.
The devolved nations.
| Nation | Items · 12 months | Data to |
|---|---|---|
| England | 37k | July 2026 |
| Scotland | 7k | June 2026 |
| Northern Ireland | 2k | May 2026 |
| Wales | 2k | April 2026 |
Each nation publishes its own community prescribing data, with different coding and list rules, so read these per-nation rather than as an exact UK total. Sources: NHSBSA (England), Public Health Scotland, NHS Wales Shared Services Partnership, OpenDataNI. Used under the Open Government Licence v3.0.
What open data won't tell you about somatropin.
List price and actual price diverge sharply for growth hormone, where competitive supply arrangements are the norm and none of them are public.
Asked and answered.
Is somatropin prescribing rising or falling in the NHS?
Falling. England dispensed 36,719 items of Somatropin in the 12 months to July 2026, down 3.1% on the previous 12 months. Items count prescriptions dispensed, not patients treated, so the change can reflect dose and duration shifts as well as patient numbers.
How much does the NHS spend on somatropin?
£20.4m at net ingredient cost in the 12 months to July 2026. Net ingredient cost is the list price of the medicine before discounts and rebates; the NHS's final bill, especially for hospital medicines, is usually lower.
Where in England is somatropin prescribed most?
By raw volume, NHS Greater Manchester ICB dispensed the most somatropin in the last 12 months. Raw volume favours the biggest populations; the map on this page shades every ICB by items per head to correct for that.
How up to date is this data?
This page runs to July 2026, the most recent NHSBSA release. Prescribing data publishes roughly six to eight weeks in arrears, and DoseTrend refreshes within 48 hours of each monthly release.
The full breakdown.
Every ICB, every prescribing organisation, every strength, the hospital view with what trusts paid and who holds each framework line, Signals with their sources, and the monthly briefing PDF. The rows below are placeholders; the real tables sit behind the application.
Track somatropin like this, every month.
£1,500 a month per molecule. Apply and we'll pre-fill Somatropin for you.